Back to top
more

Aspira Women's Health (AWH)

(Real Time Quote from BATS)

$0.87 USD

0.87
12,372

+0.01 (1.28%)

Updated Nov 8, 2024 12:10 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Alphatec (ATEC) Soars 8.4%: Is Further Upside Left in the Stock?

by Zacks Equity Research

Alphatec (ATEC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

KORU Medical Systems Inc. (KRMD) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

KORU Medical Systems Inc. (KRMD) delivered earnings and revenue surprises of 40% and 11.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Inari Medical, Inc. (NARI) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Inari Medical, Inc. (NARI) delivered earnings and revenue surprises of 20.83% and 6.13%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's Why Aspira (AWH) Looks Ripe for Bottom Fishing

by Zacks Equity Research

Aspira (AWH) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.

Down 38.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Aspira (AWH)

by Zacks Equity Research

The heavy selling pressure might have exhausted for Aspira (AWH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

Intuitive (ISRG) New Lung Biopsy Imaging Technology Gets FDA Nod

by Zacks Equity Research

The FDA clears the integration of mobile cone-beam CT imaging technology with Intuitive's (ISRG) Ion Endoluminal System, enhancing a physician's ability to provide minimally invasive lung biopsy.

Aspira (AWH) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Aspira (AWH) delivered earnings and revenue surprises of 0% and 5.35%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates

by Zacks Equity Research

Delcath Systems, Inc. (DCTH) delivered earnings and revenue surprises of -19.05% and 70%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

OPKO Health (OPK) delivered earnings and revenue surprises of 0% and 6.28%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

TransMedics (TMDX) delivered earnings and revenue surprises of -8.57% and 55.34%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Aspira (AWH) Reports Q4 Loss, Lags Revenue Estimates

by Zacks Equity Research

Aspira (AWH) delivered earnings and revenue surprises of 11.11% and 2.58%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Aspira (AWH) Reports Q3 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aspira (AWH) delivered earnings and revenue surprises of -12.50% and 11.07%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Aspira (AWH) Q3 Earnings Expected to Decline

by Zacks Equity Research

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aspira (AWH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aspira (AWH) delivered earnings and revenue surprises of 0.00% and 5.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aspira Women's Health (AWH) is Oversold: Can It Recover?

by Zacks Equity Research

Aspira Women's Health (AWH) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.

Aspira (AWH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aspira (AWH) delivered earnings and revenue surprises of 79.17% and 6.86%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Aspira (AWH) Q1 Earnings Expected to Decline

by Zacks Equity Research

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aspira (AWH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Aspira (AWH) delivered earnings and revenue surprises of -1350.00% and 11.23%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Aspira (AWH) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Aspira (AWH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Amerisafe (AMSF) Q1 Earnings Lag Estimates on Lower Premiums

by Zacks Equity Research

Amerisafe's (AMSF) earnings were affected by lower revenues stemming from a decline in premiums as the company slashed prices in order to counter a soft and competitive market.

    New Strong Sell Stocks for February 3rd

    by Zacks Equity Research

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday

      Brown & Brown (BRO) Unit Adds Insurance House to Portfolio

      by Zacks Equity Research

      Brown & Brown, Inc. (BRO) announced that Hull & Company, LLC's subsidiary has acquired the commercial MGA operations of Insurance House.

        Arthur J. Gallagher Expands in Australian Employee Benefits

        by Zacks Equity Research

        Arthur J. Gallagher & Co. (AJG) acquired Complete Financial Balance Pty Ltd in Australia.

          Allied World, Fairfax Receive Rating Action from Moody's

          by Zacks Equity Research

          Allied World Assurance Company Holdings, AG (AWH) and Fairfax Financial Holdings Limited (FRFHF) received rating action from Moody's Investors Service, a wing of Moody's Corp. (MCO).